Katherine tdm1
Webb5 dec. 2024 · Trastuzumab emtansine (T-DM1) is an antibody–drug conjugate of trastuzumab and the cytotoxic agent emtansine (DM1), a maytansine derivative and … WebbT-DM1 provides clinical benefit across patient subgroups, including small tumors and particularly high-risk tumors and does not increase the overall risk of CNS recurrence. …
Katherine tdm1
Did you know?
Webb23 maj 2024 · The new approval, announced on May 3, is based on findings from a large clinical trial called KATHERINE that compared T-DM1 with trastuzumab (Herceptin) as … Webb18 juli 2024 · Introduction. The current standard of care for the first-line treatment of human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer (MBC) is a combination regimen comprising the HER2-targeted monoclonal antibodies trastuzumab and pertuzumab plus a taxane. 1-3 The antibody-drug conjugate trastuzumab …
Webb5 apr. 2024 · Data from the pivotal phase 3 KATHERINE (NCT01772472) has led to the addition of ado-trastuzumab emtansine (T-DM1; Kadcyla) to the HER2-positive breast cancer treatment arsenal, but the toxicities associated with the approach must be appropriately managed so that patients can continue to receive it, according to Jane L. … Webb8 juni 2024 · 王树森教授：KATHERINE研究入组的人群为接受新辅助化疗后未达pCR的早期乳腺癌患者并将其随机分为两组，分别给予T-DM1和曲妥珠单抗进行抗HER2治疗。. …
Webb21 jan. 2013 · A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE) The safety and scientific validity of this study is the responsibility of the study sponsor and … Webb5 nov. 2024 · Denkert, C. et al. Biomarker data from KATHERINE: a phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients with …
Webb5 dec. 2024 · For the primary endpoint in the KATHERINE trial of invasive disease-free survival – defined as freedom from ipsilateral invasive breast tumor recurrence, ipsilateral locoregional invasive breast cancer recurrence, contralateral invasive breast cancer, distant recurrence, or death from any cause – T-DM1 was associated with a hazard …
WebbTrastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2 … chinese takeaway longhedgeWebb1 sep. 2024 · The landmark KATHERINE clinical trial randomized women with pathologic residual disease after neoadjuvant therapy to standard adjuvant trastuzumab versus … grandview portable buildingsWebb14 apr. 2024 · The KATHERINE study (NCT01772472) evaluated adjuvant T-DM1 versus trastuzumab in patients with histologically confirmed, centrally confirmed, HER2 … chinese takeaway london road isleworthWebb6 dec. 2024 · The KATHERINE investigators concluded that among patients with HER2-positive early breast cancer who had residual invasive disease after completion of neoadjuvant therapy, the risk of recurrence of invasive breast cancer or death was 50% lower with adjuvant T-DM1 than with trastuzumab alone. The study was funded by F. … chinese takeaway longhedge salisburyWebb14 apr. 2024 · The KATHERINE study (NCT01772472) evaluated adjuvant T-DM1 versus trastuzumab in patients with histologically confirmed, centrally confirmed, HER2-positive, nonmetastatic, invasive primary breast cancer [T1–4, N0–3, M0 (excluding T1aN0 and T1bN0)] at presentation, and residual invasive disease detected pathologically in the … grandview post office passportWebb26 feb. 2024 · T-DM1 was approved for the adjuvant therapy of HER2+ early BC not in pathological complete response after taxanes + anti-HER2 neoadjuvant therapy. • A phase III randomised trial revealed an increased 3-year invasive disease-free survival rate in patients receiving T-DM1 compared with trastuzumab. • chinese takeaway longford coventryWebb27 apr. 2024 · KATHERINE enrolled HER2-positive EBC patients with residual invasive disease in the breast/axilla at surgery after NACT containing a taxane (± anthracycline, … grandview post office hours